Off-label Use of Antivirals and Antimalarials for the Clinical Management of COVID-19 | Department of Health website

Skip to Main Content
Sitemap

Off-label Use of Antivirals and Antimalarials for the Clinical Management of COVID-19

Off-label Use of Antivirals and Antimalarials for the Clinical Management of COVID-19

Category:

2019-nCoV Interim Guidelines

Date:

Monday, March 16, 2020

Document Type:

Department Circular 2020-0151

File:

dc2020-0151.pdf